HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women
Open Access
- 19 January 2022
- journal article
- review article
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 7 (4) , 410-421
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association (19EIA34760167, 21PRE830396)
- National Institutes of Health
- NHLBI (1R01HL147639-01A1)
This publication has 162 references indexed in Scilit:
- Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavirAIDS, 2012
- HIV Status, Burden of Comorbid Disease, and Biomarkers of Inflammation, Altered Coagulation, and Monocyte ActivationClinical Infectious Diseases, 2012
- Soluble CD163, a Novel Marker of Activated Macrophages, Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected PatientsThe Journal of Infectious Diseases, 2011
- Soluble CD163 Made by Monocyte/Macrophages Is a Novel Marker of HIV Activity in Early and Chronic Infection Prior to and After Anti-retroviral TherapyThe Journal of Infectious Diseases, 2011
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV InfectionThe Journal of Infectious Diseases, 2011
- Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1Nature Medicine, 2009
- No Impairment of Endothelial Function or Insulin Sensitivity with 4 Weeks of the HIV Protease Inhibitors Atazanavir or Lopinavir‐Ritonavir in Healthy Subjects without HIV Infection: A Placebo‐Controlled TrialClinical Infectious Diseases, 2008
- Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral TherapyJACC, 2008
- Severe Impairment of Endothelial Function with the HIV-1 Protease Inhibitor Indinavir is not Mediated by Insulin Resistance in Healthy SubjectsCardiovascular Toxicology, 2008
- Endothelial Function in HIV-Infected PersonsClinical Infectious Diseases, 2006